Glucose transporters in health and disease: from molecular mechanisms to therapeutic applications
Metabolism and Target Organ Damage · 04.11.2026 · 6 (4)
DOI: 10.20517/mtod.2025.151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 04.11.2026. Verfasst von Maria Moreno-Lopez und 4 weiteren Autor:innen. Die Arbeit nennt 317 Literaturangaben.
Abstract (Originalsprache)
The purpose of this review is to provide a comprehensive analysis of glucose transporters, integrating molecular mechanisms, physiological roles, and therapeutic applications across health and disease states. Glucose transport across cellular membranes, mediated by facilitative glucose transporters (GLUTs) and sodium-glucose cotransporters (SGLTs), represents a fundamental control point in glucose homeostasis. Since the initial discovery of specific membrane components for glucose transfer in 1948, our understanding has evolved substantially, revealing complex tissue-specific expression patterns and regulatory mechanisms. Recent structural biology advances, genetic studies, and clinical developments, particularly the success of SGLT2 inhibitors in treating type 2 diabetes and their unexpected benefits in heart failure and chronic kidney disease, have transformed our understanding of these essential proteins. This review examines the structural and functional properties of glucose transporters, their tissue-specific distribution and regulation, their roles in metabolic organs, and their dysfunction in various diseases. We specifically address unresolved questions regarding tissue-specific regulation, expanding roles in disease pathogenesis beyond diabetes, and emerging therapeutic strategies. By synthesizing recent technological advances, clinical implications, and areas of continuing controversy, this review provides a framework for understanding both the fundamental biology of glucose transporters and their growing therapeutic significance in metabolic diseases.
Zitieren
APA
Moreno-Lopez, M., Saponaro, C., Louvet, I., Jones, J. G., & Bonner, C. (2026). Glucose transporters in health and disease: from molecular mechanisms to therapeutic applications. Metabolism and Target Organ Damage, 6(4). https://doi.org/10.20517/mtod.2025.151
Vancouver
Moreno-Lopez M, Saponaro C, Louvet I, Jones JG, Bonner C. Glucose transporters in health and disease: from molecular mechanisms to therapeutic applications. Metabolism and Target Organ Damage. 2026;6(4). doi:10.20517/mtod.2025.151
BibTeX
@article{MorenoLopez2026,
author = {Moreno-Lopez, Maria and Saponaro, Chiara and Louvet, Isaline and Jones, John Griffith and Bonner, Caroline},
title = {Glucose transporters in health and disease: from molecular mechanisms to therapeutic applications},
journal = {Metabolism and Target Organ Damage},
year = {2026},
volume = {6},
number = {4},
doi = {10.20517/mtod.2025.151}
}
EUVIMED